Cleared Traditional

K990727 - SYNEFLASH & SYNEVIEW

K990727 is an FDA 510(k) clearance for SYNEFLASH & SYNEVIEW, manufactured by Ela Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 266-day FDA review.

K990727 · Ela Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1999
Decision
266d
Days
Class 2
Risk

K990727 is an FDA 510(k) clearance for the SYNEFLASH & SYNEVIEW. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Ela Medical, Inc. (Plymouth, US). The FDA issued a Cleared decision on November 26, 1999 after a review of 266 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Ela Medical, Inc. devices

FDA 510(k) Submission Details - K990727

510(k) Number K990727 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 1999
Decision Date November 26, 1999
Days to Decision 266 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
141d slower than avg
Panel avg: 125d · This submission: 266d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 374
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K990727.
MODIFICATION TO CARTO EP NAVIGATION SYSTEM
K993729 · Biosense Webster, Inc. · Dec 1999
ENSITE 3000 SYSTEM
K992479 · Endocardial Solutions, Inc. · Dec 1999
MAC-LAB SYSTEM
K992948 · General Electric Medical Systems Information Techn · Nov 1999
IMPRESARIO
K993620 · Del Mar Medical Systems, LLC · Nov 1999
CARTO EP NAVIGATION SYSTEM
K992968 · Biosense Webster, Inc. · Sep 1999
MODIFICATION OF NOGA
K990494 · Biosense, Inc. · Sep 1999